← 홈

Antibody · 천식

8개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 8개
AntibodyAHOTFDACuratedFDABiologicSanofiApproved

dupilumab (Dupixent)

Atopic dermatitis, asthma, CRSwNP, EoE · IL-4Rα

#IL-4R#Antibody#Approved#FDA승인#바이오정보모아추천+5
효능 ORR 0.45%임상시험 255상태 APPROVED
AntibodyBstaleNovartisPhase 3

secukinumab (AIN457, AIN457 (secukinumab))

Asthma · Psoriatic Arthritis

#PsoriaticArthritis#Antibody#Phase3#인기#항체+4
효능 ORR 53%임상시험 95상태 ACTIVE
AntibodystaleRocheApproved

Omalizumab (Omalizumab)

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP); Chronic Rhinosinusitis (CRS) · Persistent Allergic Asthma

#PersistentAllergicAsthma#Antibody#Approved#인기#항체+5
임상시험 67상태 ACTIVE
AntibodystaleGSKvedotin) against targets ex…Approved

Mepolizumab (Mepolizumab)

Chronic Rhinosinusitis With Nasal Polyps; Asthma; Eosinophilic · Asthma

#Asthma#Antibody#Approved#인기#항체+5
효능 ORR 90.3%임상시험 54상태 ACTIVE
AntibodystaleAstraZenecaPreclinical

Benralizumab (Benralizumab)

Asthma · Asthma

#Asthma#Antibody#Preclinical#인기#항체+4
임상시험 53상태 ACTIVE
AntibodystaleTaipei Tzu Chi Hospital, Buddhi…Approved

Omalizimab (Omalizimab)

Asthma Patients · Asthma Patients

#AsthmaPatients#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleTevaPreclinical

Reslizumab (Reslizumab)

Asthma · Asthma

#Asthma#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleSanofiApproved

Stopping dupilumab (Stopping dupilumab)

Severe Asthma · Severe Asthma

#SevereAsthma#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING